Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian

Breadcrumb

  1. Home
  2. Functional gastrointestinal disorders from childhood to adulthood
  3. Dr. Marc Bellaiche: Managing FGIDs in children
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Functional gastrointestinal disorders from childhood to adulthood
  3. Dr. Marc Bellaiche: Managing FGIDs in children
Gastroenterology

Dr. Marc Bellaiche: Managing FGIDs in children

Functional gastrointestinal disorders
Pediatrics Gastroenterology

Dr. Marc Bellaiche is a Pediatric Gastroenterologist at the Teaching Hospital Robert Debré for Mothers and Children (Paris, France). His expertise on FGIDs in children help us underline the diagnostic complexity and raise avenues for treating the disorders under investigation (targeted pro and pre-biotics), especially in the first two years of life.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

Sections

About this article

Created 15 October 2019
Updated 12 October 2021

MANAGING FGIDs IN CHILDREN

What diagnostic difficulties do health professionals face?

As a reminder, Rome IV criteria include seven broad types of symptoms in newborns: regurgitation, cyclic vomiting, rumination, functional diarrhea, functional constipation, dyschezia, and colic (which is the most frequent FGID between 1 and 4 months of age). All health professionals are aware of the impact of FGIDs on the welfare of children and that of their parents, but general practitioners are less informed regarding Rome IV classification. Summarizing, clarifying, and spreading the criteria from the Rome Foundation would make it easier to implement current diagnostic tools, especially regarding treatment (be it medical or medico-psychological) of young children. After the age of two, childhood FGIDs look more like that of adults and are better addressed by practitioners.

Has the increasing awareness of the intestinal microbiota changed the situation?

I believe so. For instance, the definition of infant colic has been widened: etiological hypotheses are now based on the composition of the intestinal microbiota and not exclusively on standard clinical data. But treatment for FGDIs remains complicated in young children: there is more often a combination of disorders rather than a single one, as shown by a recent cohort study of 2,700 newborn children.30 Abundance of disorders explains the distress of some parents and increases difficulties to establish a diagnosis. For physicians, it is key to systematically refer to Rome IV criteria.

What are the priority therapeutic areas?

Beyond pain management, dysbiosis regulation with probiotics, is a promising therapeutic avenue. Swedish researchers were the first to work on the addition of specific strains of Lactobacillus (L. reuteri) and several studies and meta-analyses agree that these lactobacilli have proven their efficacy. According to a recent clinical study, the combination of two strains of Bifidobacterium breve could present a potential interest and decrease duration of crying in newborns with colic and fed with formula milk. Another novel concept: formulas that combine bifidogenic prebiotics (fructo-oligosaccharids and galacto-oligosaccharides) and that seem to reduce the duration of crying

Sources

30 Bellaiche M, Oozeer R, Gerardi-Temporel G, Faure C, Vandenplas Y. Multiple functional gastrointestinal disorders are frequent in formula-fed infants and decrease their quality of life. Acta Paediatr. 2018;107(7):1276-1282.

Old sources

 

 

Tags
Dysbiosis Probiotics Prebiotics Gut health Functional gastrointestinal disorders Baby Health

en_view en_sources

    Focus
    Functional gastrointestinal disorders from childhood to adulthood
    • Pathophysiology
      • Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota
      • Focus on the gut-brain axis
    • FGIDS: from infants to adults
      • In newborns
      • In children and adolescents
      • In adults
    • What could be the role of microbiota modulation?
      • Modulation of the microbiota by FMT: controversial results
      • FODMAP-free diet: not for all patients
      • Probiotics: what are the benefits?
    • Expert opinion
      • Dr. Marc Bellaiche: Managing FGIDs in children
    Created 15 October 2019
    Updated 12 October 2021

    About this article

    To know more about this topic.

    Main topic

    Functional gastrointestinal disorders

    Medical practice

    Pediatrics Gastroenterology

    Content type

    Expert opinion
    Probiotics: what are the benefits?
    Focus

    Functional gastrointestinal disorders from childhood to adulthood

    Pathophysiology

    Functional gastrointestinal disorders: a set of diseases defined in correlation with the intestinal microbiota Focus on the gut-brain axis

    FGIDS: from infants to adults

    In newborns In children and adolescents In adults

    What could be the role of microbiota modulation?

    Modulation of the microbiota by FMT: controversial results FODMAP-free diet: not for all patients Probiotics: what are the benefits?

    Expert opinion

    Dr. Marc Bellaiche: Managing FGIDs in children

    Continue reading

    News
    22.11.2021

    Irritable bowel syndrome: is fecal microbiota transplantation effective in the long term?

    Read the article
    WMD_Foundation KOL Mexico 2019
    10.06.2022

    Pr. Moisés Alvarez (Mexican winner 2019): Microbiota & colorectal cancer

    Read the article
    WMD_Foundation KOL USA 2017
    17.06.2022

    Dr. Singh (USA winner 2017): Microbiota & polyphenols

    Read the article
    WMD_Foundation KOL USA 2018
    17.06.2022

    Dr. Yang (USA winner 2018): Gut microbiota & gut brain axis

    Read the article
    WMD_Foundation KOL USA 2021
    16.06.2022

    Dr. Queen (USA winner 2020): Microbiota & colorectal cancer

    Read the article
    WMD_Foundation KOL USA 2022
    16.06.2022

    Dr. Brown (USA winner 2021): Microbiota & respiratory syncitial virus infection

    Read the article
    31.05.2022

    Pr. Maslennikov (Russian winner 2019): Probiotics & cirrhosis

    Read the article
    WMD_Foundation KOL Russia 2020
    15.06.2022

    Pr. Shifrin (Russian winner 2020): Gut microbiota & antibiotics

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Photo: Postménopause : l'action bénéfique de l'estradiol sur le microbiote vaginal
    22.06.2022

    Postmenopause: the beneficial action of estradiol on the vaginal microbiota

    Read the article
    WMD_Foundation KOL USA 2018
    17.06.2022

    Dr. Yang (USA winner 2018): Gut microbiota & gut brain axis

    Read the article
    WMD_Foundation KOL USA 2017
    17.06.2022

    Dr. Singh (USA winner 2017): Microbiota & polyphenols

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo